https://doi.org/10.5812/mejrh-119779

Cardiopulmonary Rehabilitation for Patients with Coronavirus Disease 2019 (COVID-19): A Narrative Review

authors:

avatar Mina AkbariRad ORCID 1 , avatar Mehdi Hassanzadeh Daloee 2 , avatar Mehrdad Sarabi 3 , avatar Sahar Ravanshad 1 , *

Department of Internal Medicine, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
Cardiovascular Research Center, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
Student Research Committee, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
Middle East Journal of Rehabilitation and Health Studies: Vol.9, issue 2; e119779
published online: May 9, 2022
article type: Review Article
received: October 16, 2021
revised: March 22, 2022
accepted: April 4, 2022

How To Cite AkbariRad M, Hassanzadeh Daloee M, Sarabi M, Ravanshad S. Cardiopulmonary Rehabilitation for Patients with Coronavirus Disease 2019 (COVID-19): A Narrative Review. Middle East J Rehabil Health Stud. 2022;9(2):e119779. https://doi.org/10.5812/mejrh-119779.

Abstract

The novel coronavirus-2019 (COVID-19), which spread rapidly and became a global pandemic, can cause respiratory failure, possibly requiring hospital stay or intensive care unit treatment. While COVID-19 primarily affects the respiratory system, evidence has shown that it may also affect other body organs such as the heart. Survivors of COVID-19 may develop physical, respiratory, cardiac, and psychological impairments as well as reduced quality of life. Also, the long-term consequences of COVID-19 remain unclear. Hence, cardiopulmonary rehabilitation should be started as soon as possible to alleviate dyspnea, preserve function, minimize disability, reduce complications, relieve anxiety, and improve quality of life. In this study, we summarized the current cardiopulmonary rehabilitation guidelines and protocols for patients with COVID-19.

1. Introduction

In late December 2019, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, termed COVID-19, emerged initially in Wuhan, Hubei Province, China (1, 2). The COVID-19 infection spread rapidly and evolved into a pandemic, affecting all age groups (3), even newborns (4). The most common clinical manifestations of patients with COVID-19 are dry cough, fever, fatigue, myalgia, dyspnea, nasal congestion, sore throat, and runny nose (5). Furthermore, there are different uncommon presentations such as vomiting, abdominal pain, diarrhea, loss of appetite, taste or smell dysfunction, hemoptysis, and conjunctivitis (6).

Compared to adults, most children are only detected by laboratory analysis and remain asymptomatic (7). However, disease course in some young cases may be worse and cause Guillain-Barre syndrome or Kawasaki-like signs (8, 9). The COVID-19 may develop complications in patients, including acute respiratory distress syndrome (ARDS), acute kidney injury, secondary infection, heart failure, anemia, or even multiple organ failure (5, 10).

Respiratory system and lung involvement is a significant issue in COVID-19, which can be detected by chest computed tomography (11). Respiratory involvement can lead to low blood oxygen saturation, dyspnea, and respiratory failure and eventually requires mechanical ventilation, especially in those with comorbid conditions such as ischemic heart disease, chronic obstructive pulmonary disease (COPD), obesity, diabetes mellitus, post-surgery, and cancer (12, 13). Patients with COVID-19, especially severe cases, who require intensive care unit (ICU) admission and are treated with mechanical ventilation may develop complications such as ARDS, ventilator-associated pneumonia, and pulmonary embolism (14, 15). These complications result in prolonged mechanical ventilation, prolonged stay in ICUs, and, consequently, higher mortality (14).

Post-ICU syndrome may develop in patients who stay in the ICU for a long time, which is defined as a cognitive, physical, or mental disorder during their stay in the ICU, after ICU discharge, and in the follow-up of ICU patients (16). Survivors of COVID-19 experience cardiopulmonary deconditioning, critical illness myopathy, critical illness polyneuropathy, and reduced lung function (17). Moreover, they are significantly impaired in daily living activities. As most patients with COVID-19 suffer from physical, mental, and respiratory disorders and their daily lives are affected, cardiopulmonary rehabilitation is crucial for their treatment, attracting increasing attention (18-22). Some studies demonstrated that cardiopulmonary rehabilitation could improve the quality of life and short-term physical outcomes in patients with post-ICU syndrome (23-25).

In patients with mild disease, an appropriate cardiopulmonary rehabilitation program can maintain daily living activities and exercise capacity, and also in severe cases of the disease can lead to preventing weakness related to ICUs, improve pulmonary secretion clearance, and reduce the bedridden state side effects (26). Although a cardiopulmonary rehabilitation program is crucial for patients with COVID-19, the setting is still unclear. Therefore, we conducted this study to review the different rehabilitation programs and provide evidence of their effectiveness in treating patients with COVID-19.

2. Necessity of Cardiopulmonary Rehabilitation for COVID-19 Patients

Patients who have recovered from COVID-19, especially those admitted to the ICU, need rehabilitation to effectively reduce the risk of severe disability and prevent further deterioration (27). As novel nature of COVID-19, very little is known about the need for rehabilitation as well as long-term residual deficits. However, previous members of the coronaviridae family, such as Middle East respiratory syndrome (MERS) and severe acute respiratory syndrome (SARS), revealed that patients might develop mental, physical, and social disorders post-recovery, thereby requiring rehabilitation (28-31).

Several studies revealed that cardiopulmonary rehabilitation could reduce the risk of complications, mechanical ventilation time, readmission risk, mortality rate, and length of hospital stay and improve respiratory function (32-37). In fact, cardiopulmonary rehabilitation aims at physical recovery from an acute illness by managing acute and chronic respiratory conditions (38).

3. General Recommendations for Rehabilitation of COVID-19 Patients

Since COVID-19 is highly contagious, physicians should take adequate preventive measures and use appropriate personal protective equipment. Furthermore, during exercises and rehabilitation interventions, measures must be taken to eliminate or minimize the chance of aerosol production (39). On the other hand, due to the lack of personal protective equipment and minimizing contact, rehabilitation can be done through telemedicine and can be used to initiate self-supervised rehabilitation (40).

A previous study on the utilization of telemedicine and home rehabilitation programs found that they had similar effects to center-based programs (41). One of the most important principles in the rehabilitation of patients with COVID-19 is its individualization based on the patient's needs and attention to its comorbidities (42).

Any successful rehabilitation program would have to provide education. Since COVID-19 is an emerging condition, patients may need to be educated about the disease's complications and possible effects (17). According to the available instructions, rehabilitation can be performed in the most appropriate way for outpatient patients and throughout the patient's hospitalization, including the time of patient admission, ward care, and then after discharge (43).

4. Pulmonary Rehabilitation

Pulmonary rehabilitation reduces patients' symptoms and also improves the quality of life and functional ability in patients with respiratory disease. Patients with COVID-19, especially patients admitted to the ICU, due to respiratory muscle dysfunction, peripheral muscle dysfunction (due to fatigue, ICU neuropathy, reduction of lean body mass, and hypoxemia effects), and psychosocial factors (sleep disturbance, guilt, depression, and anxiety) require pulmonary rehabilitation (44). Although most studies have reported the use and effects of pulmonary rehabilitation in patients with COPD and asthma, some studies confirmed the use of pulmonary rehabilitation in pneumonia, SARS, and interstitial lung disease, along with evidence of using pulmonary rehabilitation in the early stages of COVID-19 (45-47).

The majority of COVID-19 patients have a mild disease characterized as mild symptoms with no signs of pneumonia on imaging (48). In mild disease, patients were assigned to home care settings using telemedicine for rehabilitation. For patients with mild symptoms of COVID-19, the significant interventions of the rehabilitation program include activity guidance, breathing exercises, physical exercises, airway clearance, and education (17, 49, 50). Also, the diagnosis of COVID-19 causes a sense of fear in the patient, and as a result, anxiety management is one of the main components of rehabilitation in these patients (51). Furthermore, they should focus on general health recommendations, including smoking cessation, a balanced diet, and regular work and rest (17). Throughout the rehabilitation process, assessment and monitoring should be carried out. These recommendations for COVID-19 patients with mild disease are summarized in Table 1 (26, 52, 53).

Table 1.

Pulmonary Rehabilitation Recommendations for Patients with Mild Disease

Recommendations
Patient educationPatients must be educated about the clinical course of the disease as well as individual characteristics such as comorbidities; Educate patients about healthy lifestyle habits, including cessation of smoking, adequate sleep, plenty of fluid, and a high fiber content diet.
Airway clearingTo avoid sputum aerosolization, expectorant hygiene should be placed in a closed container; The Huff Coughing technique.
Physical activityBoth aerobic and resistance exercise should be included in physical activity; Frequency: 3 - 4 times per week, 1 - 2 times a day; Duration: Each session 15 - 45 minutes (in the first 3 - 4 sessions, 10 - 15 minutes and gradually increase); Type: Biking, walking; Intensity: ≤ 3 METs or equivalent.
Breathing exercisesTechniques: Active abdominal contraction, pursed-lip breathing, diaphragmatic breathing, Tai Chi, yoga; Frequency: 2 - 3 times per day; Duration: 10 - 15 minutes (gradually increase to 30 - 60 minutes).
Anxiety managementThe patient must be socially supported; COVID-19-infected healthcare workers must be labeled a high-risk population; Referral to psychological services.

Abbreviation: METs, metabolic equivalent of tasks.

Traditional Chinese medicine and adjuvant therapies, including acupuncture, aromatherapy, acupoint application, cupping, massage, and moxibustion, have been documented for patients with mild COVID-19 symptoms (54-57). COVID-19 patients developed moderate to severe disease in about 14% of cases, which is defined as symptomatic with a respiratory rate of > 30 beats per minute, resting oxygen saturation < 93% requiring hospitalization and monitoring (6, 48). Pulmonary rehabilitation of moderate and severe patients can be performed only when the patient's condition is assessed as stable. Moreover, to avoid exacerbation of respiratory failure or unnecessarily spreading the infection, pulmonary rehabilitation is not begun too soon in these patients (17). In addition to assessing the stability of the patient's condition, we must also consider pulmonary rehabilitation contraindications. The exclusion criteria are specified as follows (52):

• Body temperature > 38°C

• SpO2 ≤ 90%

• Blood pressure > 18/90 mmHg or < 90/60 mmHg

• Respiratory rate > 40 times per minute

• Heart rate > 120 beats per minute or < 40 beats per minute

• Initial symptom onset or diagnosis time ≤ 3 days

• Initial dyspnea onset ≤ 3 days

• New onset of myocardial ischemia or arrhythmia

• Chest imaging progression in 24 - 48 hours

• Altered level of consciousness

The two key purposes of pulmonary rehabilitation in moderate to severe patients are improving airway clearance and preventing the effects of immobility. Around 33.7% of COVID-19 patients have a high sputum production rate. Patients suffering from airway secretions benefit greatly from chest physiotherapy, enhancing cough effectiveness, improving mucociliary clearance, and encouraging efficient expectoration (58). There are five main strategies for chest physiotherapy to improve airway clearance, consisting of the following (26):

• Active cycle of breathing techniques: Patients should be actively involved in guided breathing control to reduce shortness of breath and stimulate airway secretions (59).

• Positioning: Every patient's best positioning for minimizing shortness of breath should be specific. For example, standing and leaning forward with arm support reduces shortness of breath and respiratory distress, especially in patients with COPD. During unilateral lung disease, a side-lying posture can enhance gas exchange by maximizing perfusion to the good lung (60).

• Controlled and huffing cough: These techniques are also used to enhance airway clearance and reduce coughing effort (61).

• Chest vibration and percussion: These techniques promote sputum expectoration, especially in patients with a lot of airway secretions (62).

• Flutter breathing: This device has a movable steel ball in a sealed pipe. The patient blows air into the pipe quickly, causing the steel ball to shake and generate a rhythmic airflow. Sputum in the airway can loosen due to flutter breathing (59).

Immobilization is another critical issue in the pulmonary rehabilitation of patients with moderate to severe disease. Early mobilization should be promoted once the medical situation has stabilized, including (26):

• Aerobic exercise: Aerobic exercises should have light intensity by using a level-surface walking, arm ergometer, and stationary bike. Depending on the patient's exercise tolerance, the duration of aerobic exercise will be cumulative, beginning from 5 - 10 minutes per practice session.

• Mobilization: If the patient has been medically stable, early mobilization, including level-surface ambulation, standing, unsupported sitting, stair climbing, and off-bed transferring, can be performed.

• Range of motion exercise: Active or active-assisted range of motion exercises are recommended for patients who may actively move their extremities to prevent soft tissue shortening and joint contracture as well as strengthen joint integrity.

In patients who have been on mechanical ventilation for a long time, diaphragm proteolysis can cause respiratory muscle weakness. In these patients, inspiratory and expiratory muscle exercise can begin with incentive spirometry and advance to inspiratory muscle training devices if accessible (63, 64). Patients who are recovered from ICU support will use the same techniques. Because of the deconditioning, that happens in the ICU, an emphasis on bed mobility and breathing exercises may be the first intervention for these patients. Sit-to-stand at bedside, over-head arm stretches, sliding legs into extension/flexion, and ankle pumps are some bed mobility movements (52).

5. Evidence for Pulmonary Rehabilitation of COVID-19 Patients

Some studies have looked at the effects of pulmonary rehabilitation in COVID-19 patients. Liu et al. (32) conducted a prospective, quasi-experimental study in China on pulmonary rehabilitation in patients with COVID-19 who had been weaned off mechanical ventilation and discharged from the hospital. Over the course of six weeks, respiratory function (FEV1/FVC), physical function, anxiety level, and quality of life of patients improved. Besides, they reported that depression had no significant improvement during the six weeks (32).

Daynes et al. conducted another study on 30 patients who underwent a 6-week, twice-supervised rehabilitation program post-COVID-19 (65). They demonstrated that rehabilitation following COVID-19 is feasible and significantly improves respiratory symptoms, exercise capacity, cognition, and fatigue (65). A prospective study of 99 post-COVID-19 patients who were referred for pulmonary rehabilitation in Switzerland revealed that comprehensive pulmonary rehabilitation results in significant improvement in the 6-min walk test (P < 0.001), the feeling thermometer (P < 0.001), and functional independence measurement (P < 0.001) (66).

6. Cardiac Rehabilitation

COVID-19 patients, like those infected with other coronaviridae, are at risk for cardiac complications, especially myocardial injury and arrhythmias (67-69). These complications may cause by hypotension, ACE2-receptor downregulation, hypoxia, and viral myocardial injury (70).

The American Heart Association (AHA) and the American Cardiology Association (ACC) also highly advocate cardiac rehabilitation for the care of patients with coronary artery disease and chronic heart failure (71). For cardiac rehabilitation, the British Association for Cardiovascular Prevention and Rehabilitation provides the six key components (72):

• Medical risk factor management

• Healthy behavior changes and education

• Lon-term management

• Psychological health

• Lifestyle risk management

• Audit and evaluation

Cardiac rehabilitation can reduce morbidity, mortality, and hospital admission while enhancing the quality of life, psychological well-being, and exercise capacity (72, 73). Depending on the complications and patients’ symptoms, a period of rest following infection will reduce the risk of myocarditis-related post-infection heart failure (53). Following reported myocarditis, patients must rest for 3 - 6 months before returning to high-level sport or physically challenging work (53). The length of rest is determined by the duration and severity of the infection, and the level of inflammation on cardiovascular magnetic resonance imaging and the left ventricular function at the time of onset. These patients should be re-evaluated periodically for the first two years (53).

7. Cardiopulmonary Rehabilitation Guidelines for COVID-19 Patients

Some consensus-based guidelines from different countries suggest feasible and practical rehabilitation methods for patients with COVID-19. In all these guidelines, the short-term goal of rehabilitation is to reduce shortness of breath and alleviate the patient's depression and anxiety, and the long-term goal is to improve the patient's quality of life, maintain the patient's performance to the maximum extent, and facilitate reintegration into society. Moreover, comprehensive assessments should be performed on patients prior to initiating the rehabilitation program. The recommendation guidelines by the UK, Turkish, Italian, Chinese, and multinational rehabilitation professionals are summarized in Table 2 (38, 49, 53, 74, 75).

Table 2.

Cardiopulmonary Rehabilitation Guidelines for Patients with COVID-19

GuidelinesCountryRecommendations
Zheng et al. (19)ChinaThis clinical practice guideline explains WHO International Family Classifications approaches and framework to set up an expert consensus on rehabilitation of COVID-19 patients.
Rehabilitation measures in this framework are divided into four categories: preventive, palliative, health-promoting, and therapeutic care.
Health promotion and preventive care are mainly used for outpatient care (after discharge), while therapeutic care can be provided for inpatients.
PR comprises respiratory training, expectoration therapy, and thorax mobilizing exercise to relieve patients' complaints.
Body posture can affect the ventilation/perfusion ratio, diaphragm performance, and simplicity of breathing.
Cough expectoration is aided by adjustments in body posture, thoracic vibration, clapping, and active breathing.
Resistant breathing conditioning that is graded and gradual enhances breathing experience.
Exercise training such as aerobic, coordination, and balance training primarily improves the cardiopulmonary muscle and increases the compensatory ability of non-involved organs.
Aerobic, coordination, and balance training mainly improve the cardiopulmonary muscle while enhancing the compensatory capacity of non-involved organs.
Nevertheless, because of the cooperation between the physician and the physiotherapist, exercise training in COVID-19 should be thoroughly evaluated.
Kurtais Aytur et al. (75)TurkeyThis guideline clarifies PR principles for COVID-19 cases, taking into account the disease's contagiousness, suggestions for limiting a patient's interaction with physicians, and the evidence for PR's potential benefits.
Mild disease stage: PR is not recommended; PR is only recommended for patients with disabilities such as immobility, immunodeficiency, cardiac, chronic lung, and neurologic disease; General health recommendations, including cessation of smoking, taking protein, selenium, zinc, vitamin C, plenty of fluid, and high fiber content diet.
Mild pneumonia stage: Individualized PR (at home, single session) for COVID-19 mild pneumonia after stabilization of patient’s condition and virulence reduction; Special care for patients with disability that should be evaluated by a physical medicine and rehabilitation specialists; General health recommendations; It is suggested that patients undergo daily follow-up; Use personal protective equipment.
Severe pneumonia stage: Individualized PR after evaluation by physical medicine and rehabilitation specialists; Medical stability in these patients is a necessity; Discontinue PR if the patient's general health and pulmonary findings deteriorate; Use personal protective equipment.
Acute ARDS stage: PR is not recommended for COVID-19 patients at the ARDS stage; General rehabilitation cares such as joint range of motion, airway clearance, early mobilization, and bed positioning.
Barker-Davies et al. (53)UKThe Stanford Hall consensus statement recommends a rehabilitation program for COVID-19 patients at an individual level, specific to cardiac, pulmonary, musculoskeletal, and psychological, based on the Likert scale agreement score (0 - 10).
PR recommendations: In post-COVID-19 patients, respiratory complications must be considered (Level of agreement: 95% CI: 8.92 - 9.85, mean score 9.38); The initial evaluation is advised early as possible based on patient’s mental and physical condition, normocapnic respiratory failure, degree of dysfunction, and safety issue (level of agreement: 95% CI: 8.48 to 9.52, mean score 9.00); In patients on oxygen therapy, low-intensity exercise must be addressed. Also, increase the exercise's intensity by evaluating the patient's symptoms (level of agreement: 95% CI: 8.23 to 9.57, mean score 8.90).
CR recommendations: In post-COVID-19 patients, cardiac complications must be considered (Level of agreement: 95% CI: 7.77 to 9.28, mean score 8.52); Depending on the patient's complications and symptoms, a rest period post-COVID-19 infection reduces the risk of heart failure secondary to myocarditis (Level of agreement: 95% CI: 8.70 to 9.68, mean score 9.19); Specific cardiac rehabilitation programs tailored to each individual's based on cardiac pathology (level of agreement: 95% CI: 9.03 to 9.82, mean score 9.43); Patients with confirmed myocarditis need a full 3-6 months of rest to return to high-level exercise or physical activity (level of agreement: 95% CI: 8.64 to 9.74, mean score 9.19); Patients with myocarditis who return to high-level exercise or physical activity should be re-evaluated periodically for the first two years (level of agreement: 95% CI: 8.65 to 9.44, mean score 9.05).
Thomas et al. (38)MultinationalThis guideline recommends instructions for the physiotherapy management of inpatients COVID-19 patients.
These recommendations include determining the need for physiotherapy, using the physiotherapy workforce, and physiotherapy treatments (PR and use of personal protective equipment) for patients with COVID-19.
Cardiopulmonary Rehabilitation Group of Chinese Society of Physical Medicine and Rehabilitation (49)ChinaThe Chinese Association of Rehabilitation Medicine outlines five recommendations for rehabilitation of elderly COVID-19 patients:
PR enhances depression, anxiety, and breathlessness, as well as quality of life and physical activity in COVID-19 inpatients.
PR is not recommended in critically ill patients.
Recommended PR teleconsultation for COVID-19 patients.
Safety measures must be observed for all personnel involved in PR.
During PR, regular monitoring is recommended.

Abbreviation: CR, cardiac rehabilitation; PR, pulmonary rehabilitation; CI, confidence interval; ARDS, acute respiratory distress syndrome; WHO, World Health Organization.

8. Conclusions

Current knowledge recommends that cardiopulmonary rehabilitation must be provided along with the treatment process, whether the patient is at home or in the hospital. Furthermore, rehabilitation programs should be personalized to the different needs of the patient. Physicians' safety is essential in rehabilitation interventions, and contact isolation and personal protective equipment must be strictly observed. Finally, an appropriate rehabilitation program can reduce the length of hospital stay, and improve cardiopulmonary function, physical efficiency, and patients' quality of life.

References

  • 1.

    Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Engl J Med. 2020;382(8):727-33. [PubMed ID: 31978945]. [PubMed Central ID: PMC7092803]. https://doi.org/10.1056/NEJMoa2001017.

  • 2.

    Wu JT, Leung K, Leung GM. Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study. Lancet. 2020;395(10225):689-97. https://doi.org/10.1016/s0140-6736(20)30260-9.

  • 3.

    Ludvigsson JF. Systematic review of COVID-19 in children shows milder cases and a better prognosis than adults. Acta Paediatr. 2020;109(6):1088-95. [PubMed ID: 32202343]. [PubMed Central ID: PMC7228328]. https://doi.org/10.1111/apa.15270.

  • 4.

    Farhat AS, Sayedi SJ, Akhlaghi F, Hamedi A, Ghodsi A. Coronavirus (COVID-19) infection in newborns. Int J Pediatr. 2020;8(6):11513-7.

  • 5.

    Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497-506. https://doi.org/10.1016/s0140-6736(20)30183-5.

  • 6.

    Wu Z, McGoogan JM. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72314 Cases From the Chinese Center for Disease Control and Prevention. JAMA. 2020;323(13):1239-42. [PubMed ID: 32091533]. https://doi.org/10.1001/jama.2020.2648.

  • 7.

    Ghodsi A, Azarfar A, Ghahremani S. A Review of Coronavirus Disease (COVID-19) in Children. J Pediatr Nephrol. 2020;8(3).

  • 8.

    Khalifa M, Zakaria F, Ragab Y, Saad A, Bamaga A, Emad Y, et al. Guillain-Barre Syndrome Associated With Severe Acute Respiratory Syndrome Coronavirus 2 Detection and Coronavirus Disease 2019 in a Child. J Pediatric Infect Dis Soc. 2020;9(4):510-3. [PubMed ID: 32652520]. [PubMed Central ID: PMC7454732]. https://doi.org/10.1093/jpids/piaa086.

  • 9.

    Ghodsi A, Malek A, Ghahremani S. A Review of Multisystem Inflammatory Syndrome in Children (MIS-C) Associated with COVID-19. Hormozgan Med J. 2020;24(4). https://doi.org/10.5812/hmj.107048.

  • 10.

    Hu Z, Song C, Xu C, Jin G, Chen Y, Xu X, et al. Clinical characteristics of 24 asymptomatic infections with COVID-19 screened among close contacts in Nanjing, China. Sci China Life Sci. 2020;63(5):706-11. [PubMed ID: 32146694]. [PubMed Central ID: PMC7088568]. https://doi.org/10.1007/s11427-020-1661-4.

  • 11.

    Ghodsi A, Bijari M, Alamdaran SA, Saberi A, Mahmoudabadi E, Balali MR, et al. Chest computed tomography findings of COVID-19 in children younger than 1 year: a systematic review. World J Pediatr. 2021;17(3):1–8. [PubMed ID: 33963512]. [PubMed Central ID: PMC8104919]. https://doi.org/10.1007/s12519-021-00424-1.

  • 12.

    Guo YR, Cao QD, Hong ZS, Tan YY, Chen SD, Jin HJ, et al. The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak - an update on the status. Mil Med Res. 2020;7(1):1–10. [PubMed ID: 32169119]. [PubMed Central ID: PMC7068984]. https://doi.org/10.1186/s40779-020-00240-0.

  • 13.

    Lei S, Jiang F, Su W, Chen C, Chen J, Mei W, et al. Clinical characteristics and outcomes of patients undergoing surgeries during the incubation period of COVID-19 infection. EClinicalMedicine. 2020;21:100331. [PubMed ID: 32292899]. [PubMed Central ID: PMC7128617]. https://doi.org/10.1016/j.eclinm.2020.100331.

  • 14.

    Boyer AF, Schoenberg N, Babcock H, McMullen KM, Micek ST, Kollef MH. A prospective evaluation of ventilator-associated conditions and infection-related ventilator-associated conditions. Chest. 2015;147(1):68-81. [PubMed ID: 24854003]. https://doi.org/10.1378/chest.14-0544.

  • 15.

    Murthy S, Gomersall CD, Fowler RA. Care for Critically Ill Patients With COVID-19. JAMA. 2020;323(15):1499-500. [PubMed ID: 32159735]. https://doi.org/10.1001/jama.2020.3633.

  • 16.

    Muscedere J, Sinuff T, Heyland DK, Dodek PM, Keenan SP, Wood G, et al. The clinical impact and preventability of ventilator-associated conditions in critically ill patients who are mechanically ventilated. Chest. 2013;144(5):1453-60. [PubMed ID: 24030318]. https://doi.org/10.1378/chest.13-0853.

  • 17.

    Zhao HM, Xie YX, Wang C. Recommendations for respiratory rehabilitation in adults with coronavirus disease 2019. Chin Med J (Engl). 2020;133(13):1595-602. [PubMed ID: 32251002]. [PubMed Central ID: PMC7470013]. https://doi.org/10.1097/CM9.0000000000000848.

  • 18.

    Vitacca M, Carone M, Clini EM, Paneroni M, Lazzeri M, Lanza A, et al. Joint Statement on the Role of Respiratory Rehabilitation in the COVID-19 Crisis: The Italian Position Paper. Respiration. 2020;99(6):493-9. [PubMed ID: 32428909]. [PubMed Central ID: PMC7316664]. https://doi.org/10.1159/000508399.

  • 19.

    Zheng C, Li Z, Duan C, Zhang Y, Li Q, Dou Z, et al. Rehabilitation needs of the first cohort of post-acute COVID-19 patients in Hubei, China. Eur J Phys Rehabil Med. 2020;56(3):339-44. [PubMed ID: 32672029]. https://doi.org/10.23736/S1973-9087.20.06298-X.

  • 20.

    Sun T, Guo L, Tian F, Dai T, Xing X, Zhao J, et al. Rehabilitation of patients with COVID-19. Expert Rev Respir Med. 2020;14(12):1249-56. [PubMed ID: 32799694]. https://doi.org/10.1080/17476348.2020.1811687.

  • 21.

    Ghodsi A, Sarabi M, Malek A, Khakshour A. Current Treatment Guidelines of SARS-CoV-2 Related Multisystem Inflammatory Syndrome in Children: A Literature Review and Expert Opinion. J Child Sci. 2021;11(1):e133-40. https://doi.org/10.1055/s-0041-1731077.

  • 22.

    Ehsani F, Reshadat S, Masoudian N, Bagheri R. Evaluation of the Relationship Between Daily Physical Activity Level and Laboratory Factors and the Length of Hospitalization in Patients with COVID-19. Middle East J Rehabil Health Stud. 2021;8(4). https://doi.org/10.5812/mejrh.114607.

  • 23.

    Brown SM, Bose S, Banner-Goodspeed V, Beesley SJ, Dinglas VD, Hopkins RO, et al. Approaches to Addressing Post-Intensive Care Syndrome among Intensive Care Unit Survivors. A Narrative Review. Ann Am Thorac Soc. 2019;16(8):947-56. [PubMed ID: 31162935]. https://doi.org/10.1513/AnnalsATS.201812-913FR.

  • 24.

    Hermann M, Pekacka-Egli AM, Witassek F, Baumgaertner R, Schoendorf S, Spielmanns M. Feasibility and Efficacy of Cardiopulmonary Rehabilitation After COVID-19. Am J Phys Med Rehabil. 2020;99(10):865-9. [PubMed ID: 32732746]. [PubMed Central ID: PMC7406212]. https://doi.org/10.1097/PHM.0000000000001549.

  • 25.

    Teo SP. Planning Rehabilitation and Allied Health Professional Input for Older Inpatients During the COVID-19 Pandemic. Middle East J Rehabil Health Stud. 2020;8(1). https://doi.org/10.5812/mejrh.106695.

  • 26.

    Cheng YY, Chen CM, Huang WC, Chiang SL, Hsieh PC, Lin KL, et al. Rehabilitation programs for patients with COronaVIrus Disease 2019: consensus statements of Taiwan Academy of Cardiovascular and Pulmonary Rehabilitation. J Formos Med Assoc. 2021;120(1 Pt 1):83-92. [PubMed ID: 32863084]. [PubMed Central ID: PMC7430281]. https://doi.org/10.1016/j.jfma.2020.08.015.

  • 27.

    Boldrini P, Bernetti A, Fiore P. Impact of COVID-19 outbreak on rehabilitation services and Physical and Rehabilitation Medicine physicians' activities in Italy. An official document of the Italian PRM Society (SIMFER). Eur J Phys Rehabil Med. 2020;56(3):315-8. [PubMed ID: 32175719]. https://doi.org/10.23736/S1973-9087.20.06256-5.

  • 28.

    Batawi S, Tarazan N, Al-Raddadi R, Al Qasim E, Sindi A, Al Johni S, et al. Quality of life reported by survivors after hospitalization for Middle East respiratory syndrome (MERS). Health Qual Life Outcomes. 2019;17(1):1–7. [PubMed ID: 31186042]. [PubMed Central ID: PMC6560892]. https://doi.org/10.1186/s12955-019-1165-2.

  • 29.

    Gomersall CD, Chan DP, Leung P, Joynt GM, Hui DS. Long term outcome of acute respiratory distress syndrome caused by severe acute respiratory syndrome (SARS): an observational study. Crit Care Resusc. 2006;8(4).

  • 30.

    Ricks E. Critical illness polyneuropathy and myopathy: a review of evidence and the implications for weaning from mechanical ventilation and rehabilitation. Physiotherapy. 2007;93(2):151-6. https://doi.org/10.1016/j.physio.2006.09.005.

  • 31.

    Kim JE, Heo JH, Kim HO, Song SH, Park SS, Park TH, et al. Neurological Complications during Treatment of Middle East Respiratory Syndrome. J Clin Neurol. 2017;13(3):227-33. [PubMed ID: 28748673]. [PubMed Central ID: PMC5532318]. https://doi.org/10.3988/jcn.2017.13.3.227.

  • 32.

    Liu K, Zhang W, Yang Y, Zhang J, Li Y, Chen Y. Respiratory rehabilitation in elderly patients with COVID-19: A randomized controlled study. Complement Ther Clin Pract. 2020;39:101166. [PubMed ID: 32379637]. [PubMed Central ID: PMC7118596]. https://doi.org/10.1016/j.ctcp.2020.101166.

  • 33.

    Jiang Y, Chen J, Cen F, Li X, Song Z, Peng M, et al. Importance of respiratory airway management as well as psychological and rehabilitative treatments to COVID-19 patients. Am J Emerg Med. 2020;38(8):1698 e1-4. [PubMed ID: 32601006]. [PubMed Central ID: PMC7192120]. https://doi.org/10.1016/j.ajem.2020.04.055.

  • 34.

    Zhu C, Wu Y, Liu H, Ban Y, Ma X, Zhang Z. Early pulmonary rehabilitation for SARS-CoV-2 pneumonia: Experience from an intensive care unit outside of the Hubei province in China. Heart Lung. 2020;49(5):449-50. [PubMed ID: 32312554]. [PubMed Central ID: PMC7161510]. https://doi.org/10.1016/j.hrtlng.2020.04.007.

  • 35.

    Lai CC, Chou W, Chan KS, Cheng KC, Yuan KS, Chao CM, et al. Early Mobilization Reduces Duration of Mechanical Ventilation and Intensive Care Unit Stay in Patients With Acute Respiratory Failure. Arch Phys Med Rehabil. 2017;98(5):931-9. [PubMed ID: 27979608]. https://doi.org/10.1016/j.apmr.2016.11.007.

  • 36.

    Hsieh MJ, Lee WC, Cho HY, Wu MF, Hu HC, Kao KC, et al. Recovery of pulmonary functions, exercise capacity, and quality of life after pulmonary rehabilitation in survivors of ARDS due to severe influenza A (H1N1) pneumonitis. Influenza Other Respir Viruses. 2018;12(5):643-8. [PubMed ID: 29676537]. [PubMed Central ID: PMC6086854]. https://doi.org/10.1111/irv.12566.

  • 37.

    Akbari A, Fathabadi A, Razmi M, Zarifian A, Amiri M, Ghodsi A, et al. Characteristics, risk factors, and outcomes associated with readmission in COVID-19 patients: A systematic review and meta-analysis. Am J Emerg Med. 2022;52:166-73. [PubMed ID: 34923196]. [PubMed Central ID: PMC8665665]. https://doi.org/10.1016/j.ajem.2021.12.012.

  • 38.

    Thomas P, Baldwin C, Bissett B, Boden I, Gosselink R, Granger CL, et al. Physiotherapy management for COVID-19 in the acute hospital setting: clinical practice recommendations. J Physiother. 2020;66(2):73-82. [PubMed ID: 32312646]. [PubMed Central ID: PMC7165238]. https://doi.org/10.1016/j.jphys.2020.03.011.

  • 39.

    Kemps HMC, Brouwers RWM, Cramer MJ, Jorstad HT, de Kluiver EP, Kraaijenhagen RA, et al. Recommendations on how to provide cardiac rehabilitation services during the COVID-19 pandemic. Neth Heart J. 2020;28(7-8):387-90. [PubMed ID: 32676982]. [PubMed Central ID: PMC7364293]. https://doi.org/10.1007/s12471-020-01474-2.

  • 40.

    Kilova K, Kitova T, Kasnakova P. Telemedicine in help of rehabilitation in the conditions of COVID-19. Health Policy Technol. 2021;10(2):100508. [PubMed ID: 33850698]. [PubMed Central ID: PMC8026262]. https://doi.org/10.1016/j.hlpt.2021.100508.

  • 41.

    Alison JA, McKeough ZJ, Johnston K, McNamara RJ, Spencer LM, Jenkins SC, et al. Australian and New Zealand Pulmonary Rehabilitation Guidelines. Respirology. 2017;22(4):800-19. [PubMed ID: 28339144]. https://doi.org/10.1111/resp.13025.

  • 42.

    Wouters EFM, Wouters B, Augustin IML, Houben-Wilke S, Vanfleteren L, Franssen FME. Personalised pulmonary rehabilitation in COPD. Eur Respir Rev. 2018;27(147). [PubMed ID: 29592864]. https://doi.org/10.1183/16000617.0125-2017.

  • 43.

    Phillips M, Turner-Stokes L, Wade D, Walton K. Rehabilitation in the wake of Covid-19-a Phoenix from the ashes. Br Soc Rehabil Med. 2020;1(2):1-20.

  • 44.

    Siddiq MAB, Rathore FA, Clegg D, Rasker JJ. Pulmonary Rehabilitation in COVID-19 patients: A scoping review of current practice and its application during the pandemic. Turk J Phys Med Rehabil. 2020;66(4):480-94. [PubMed ID: 33364571]. [PubMed Central ID: PMC7756838]. https://doi.org/10.5606/tftrd.2020.6889.

  • 45.

    Cheng HH, Chou W. Rehabilitation can reduce mortality rate in patients who were intubated due to pneumonia. Ann Phys Rehabil Med. 2018;61:e280-1. https://doi.org/10.1016/j.rehab.2018.05.655.

  • 46.

    Rice H, Harrold M, Fowler R, Watson C, Waterer G, Hill K. Exercise training for adults hospitalized with an acute respiratory condition: a systematic scoping review. Clin Rehabil. 2020;34(1):45-55. [PubMed ID: 31552759]. https://doi.org/10.1177/0269215519877930.

  • 47.

    Lau HM, Ng GY, Jones AY, Lee EW, Siu EH, Hui DS. A randomised controlled trial of the effectiveness of an exercise training program in patients recovering from severe acute respiratory syndrome. Aust J Physiother. 2005;51(4):213-9. https://doi.org/10.1016/s0004-9514(05)70002-7.

  • 48.

    Lin L, Li TS. interpretation of" guidelines for the diagnosis and treatment of novel coronavirus (2019-ncov) infection by the national health commission (trial version 5)". Zhonghua Yi Xue Za Zhi. 2020;100. E001.

  • 49.

    Cardiopulmonary Rehabilitation Group of Chinese Society of Physical Medicine and Rehabilitation. Recommendations for respiratory rehabilitation of coronavirus disease 2019 in adult. Zhonghua Jie He He Hu Xi Za Zhi. 2020;43(4):308-14.

  • 50.

    Rayegani SM, Raeissadat SA, Fakharian A, Babaee M, Nezamabadi M, Boland Nazar NS, et al. Role of rehabilitation medicine in the COVID-19 pandemic: an Iranian consensus. Eur J Phys Rehabil Med. 2021;57(2):309-10. [PubMed ID: 32558523]. https://doi.org/10.23736/S1973-9087.20.06366-2.

  • 51.

    Wang C, Pan R, Wan X, Tan Y, Xu L, Ho CS, et al. Immediate Psychological Responses and Associated Factors during the Initial Stage of the 2019 Coronavirus Disease (COVID-19) Epidemic among the General Population in China. Int J Environ Res Public Health. 2020;17(5). [PubMed ID: 32155789]. [PubMed Central ID: PMC7084952]. https://doi.org/10.3390/ijerph17051729.

  • 52.

    Wang TJ, Chau B, Lui M, Lam G, Lin N, Humbert S. PM&R and pulmonary rehabilitation for COVID-19. Am J Phys Med Rehabil. 2020.

  • 53.

    Barker-Davies RM, O'Sullivan O, Senaratne KPP, Baker P, Cranley M, Dharm-Datta S, et al. The Stanford Hall consensus statement for post-COVID-19 rehabilitation. Br J Sports Med. 2020;54(16):949-59. [PubMed ID: 32475821]. [PubMed Central ID: PMC7418628]. https://doi.org/10.1136/bjsports-2020-102596.

  • 54.

    Liu WH, Guo SN, Wang F, Hao Y. Understanding of guidance for acupuncture and moxibustion interventions on COVID-19 issued by CAAM. World J Acupunct Moxibustion. 2020;30(1):1-4. [PubMed ID: 32292259]. [PubMed Central ID: PMC7118592]. https://doi.org/10.1016/j.wjam.2020.03.005.

  • 55.

    Zhao Z, Li Y, Zhou L, Zhou X, Xie B, Zhang W, et al. Prevention and treatment of COVID-19 using Traditional Chinese Medicine: A review. Phytomedicine. 2021;85:153308. [PubMed ID: 32843234]. [PubMed Central ID: PMC7439087]. https://doi.org/10.1016/j.phymed.2020.153308.

  • 56.

    Li XD, Liu BY, Wang Y, Guan L, Li GX, Wang H, et al. Interpretation of recommendation on the rehabilitation guidance of traditional Chinese medicine for coronavirus disease in the recovery period (trial). J Tradit Chin Med. 2020;61(11):928-34.

  • 57.

    Chen X, Huang W, Liu B, Wang H, He L, Zhao H, et al. Moxibustion therapy in prevention and treatment of coronavirus disease 2019 (COVID-19): construction and application of non-contact diagnosis and treatment mode. Zhongguo Zhen Jiu. 2020:1027-33.

  • 58.

    Strickland SL, Rubin BK, Drescher GS, Haas CF, O'Malley CA, Volsko TA, et al. AARC clinical practice guideline: effectiveness of nonpharmacologic airway clearance therapies in hospitalized patients. Respir Care. 2013;58(12):2187-93. [PubMed ID: 24222709]. https://doi.org/10.4187/respcare.02925.

  • 59.

    Uzmezoglu B, Altiay G, Ozdemir L, Tuna H, Sut N. The Efficacy of Flutter((R)) and Active Cycle of Breathing Techniques in Patients with Bronchiectasis: A Prospective, Randomized, Comparative Study. Turk Thorac J. 2018;19(3):103-9. [PubMed ID: 30083399]. [PubMed Central ID: PMC6077004]. https://doi.org/10.5152/TurkThoracJ.2018.17050.

  • 60.

    Campbell ML. Dyspnea. AACN Adv Crit Care. 2011;22(3):257-64. [PubMed ID: 21808161]. https://doi.org/10.1097/NCI.0b013e318220bc4d.

  • 61.

    Pryor JA. Physiotherapy for airway clearance in adults. Eur Respir J. 1999;14(6):1418-24. [PubMed ID: 10624775]. https://doi.org/10.1183/09031936.99.14614189.

  • 62.

    Lee AL, Burge AT, Holland AE. Airway clearance techniques for bronchiectasis. Cochrane Database Syst Rev. 2015;(11). CD008351. [PubMed ID: 26591003]. [PubMed Central ID: PMC7175838]. https://doi.org/10.1002/14651858.CD008351.pub3.

  • 63.

    Bissett B, Gosselink R, van Haren FMP. Respiratory Muscle Rehabilitation in Patients with Prolonged Mechanical Ventilation: A Targeted Approach. Ann Update Intensive Care Emerg Med. 2020:595-609. https://doi.org/10.1007/978-3-030-37323-8_45.

  • 64.

    Paiva DN, Assmann LB, Bordin DF, Gass R, Jost RT, Bernardo-Filho M, et al. Inspiratory muscle training with threshold or incentive spirometry: Which is the most effective? Rev Port Pneumol (2006). 2015;21(2):76-81. [PubMed ID: 25926370]. https://doi.org/10.1016/j.rppnen.2014.05.005.

  • 65.

    Daynes E, Gerlis C, Chaplin E, Gardiner N, Singh SJ. Early experiences of rehabilitation for individuals post-COVID to improve fatigue, breathlessness exercise capacity and cognition - A cohort study. Chron Respir Dis. 2021;18:14799731211015700. [PubMed ID: 33957805]. [PubMed Central ID: PMC8114752]. https://doi.org/10.1177/14799731211015691.

  • 66.

    Spielmanns M, Pekacka-Egli AM, Schoendorf S, Windisch W, Hermann M. Effects of a Comprehensive Pulmonary Rehabilitation in Severe Post-COVID-19 Patients. Int J Environ Res Public Health. 2021;18(5). [PubMed ID: 33800094]. [PubMed Central ID: PMC7967422]. https://doi.org/10.3390/ijerph18052695.

  • 67.

    Madjid M, Safavi-Naeini P, Solomon SD, Vardeny O. Potential Effects of Coronaviruses on the Cardiovascular System: A Review. JAMA Cardiol. 2020;5(7):831-40. [PubMed ID: 32219363]. https://doi.org/10.1001/jamacardio.2020.1286.

  • 68.

    Ghodsi A, Mahmoudabadi E, Ghahremani S, Malek A. Cardiac Manifestations of Multisystem Inflammatory Syndrome in Children (MIS-C) Associated with SARS-CoV-2 Infection. Arch Pediatr Infect Dis. 2021;9(4). https://doi.org/10.5812/pedinfect.109915.

  • 69.

    Heidari Bakavoli A, Ghodsi A, Omranzadeh A, Bijari M, Hosseini S. Cardiac arrhythmia due to ledipasvir/sofosbuvir Iranian counterpart, commercially named as Ledibiox: A case report. J Cardio-Thorac Med. 2020;8(3):679-83.

  • 70.

    Kochi AN, Tagliari AP, Forleo GB, Fassini GM, Tondo C. Cardiac and arrhythmic complications in patients with COVID-19. J Cardiovasc Electrophysiol. 2020;31(5):1003-8. [PubMed ID: 32270559]. [PubMed Central ID: PMC7262150]. https://doi.org/10.1111/jce.14479.

  • 71.

    Scherrenberg M, Frederix I, De Sutter J, Dendale P. Use of cardiac telerehabilitation during COVID-19 pandemic in Belgium. Acta Cardiol. 2021;76(7):773-6. [PubMed ID: 32602812]. https://doi.org/10.1080/00015385.2020.1786625.

  • 72.

    Cowie A, Buckley J, Doherty P, Furze G, Hayward J, Hinton S, et al. Standards and core components for cardiovascular disease prevention and rehabilitation. Heart. 2019;105(7):510-5. [PubMed ID: 30700518]. [PubMed Central ID: PMC6580752]. https://doi.org/10.1136/heartjnl-2018-314206.

  • 73.

    Kamiya K, Sato Y, Takahashi T, Tsuchihashi-Makaya M, Kotooka N, Ikegame T, et al. Multidisciplinary Cardiac Rehabilitation and Long-Term Prognosis in Patients With Heart Failure. Circ Heart Fail. 2020;13(10). e006798. [PubMed ID: 32986957]. https://doi.org/10.1161/CIRCHEARTFAILURE.119.006798.

  • 74.

    Lazzeri M, Lanza A, Bellini R, Bellofiore A, Cecchetto S, Colombo A, et al. Respiratory physiotherapy in patients with COVID-19 infection in acute setting: a Position Paper of the Italian Association of Respiratory Physiotherapists (ARIR). Monaldi Arch Chest Dis. 2020;90(1). https://doi.org/10.4081/monaldi.2020.1285.

  • 75.

    Kurtais Aytur Y, Koseoglu BF, Ozyemisci Taskiran O, Ordu-Gokkaya NK, Unsal Delialioglu S, Sonel Tur B, et al. Pulmonary rehabilitation principles in SARS-COV-2 infection (COVID-19): A guideline for the acute and subacute rehabilitation. Turk J Phys Med Rehabil. 2020;66(2):104-20. [PubMed ID: 32760887]. [PubMed Central ID: PMC7401689]. https://doi.org/10.5606/tftrd.2020.6444.